Catalyst Wire Dossier Catalyst Wire Dossier

TAF/FTC/BIC

tenofovir alafenamide/emtricitabine/bictegravir · Gilead Sciences
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TAF/FTC/BIC, covering 2022-06-10 to 2025-02-17. Get the full timeline:

Most recent: Clinical Trial Update: Real-Life Outcomes of TAF/FTC/BIC in HIV Patients in Colombia

See pricing